nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—CYP2C9—Gefitinib—lung cancer	0.0774	0.245	CbGbCtD
Agomelatine—CYP2C9—Teniposide—lung cancer	0.0751	0.238	CbGbCtD
Agomelatine—CYP1A2—Erlotinib—lung cancer	0.0508	0.161	CbGbCtD
Agomelatine—CYP2C9—Paclitaxel—lung cancer	0.0419	0.133	CbGbCtD
Agomelatine—CYP1A2—Etoposide—lung cancer	0.0367	0.116	CbGbCtD
Agomelatine—CYP2C9—Cisplatin—lung cancer	0.0337	0.107	CbGbCtD
Agomelatine—Melatonin—MT3—lung cancer	0.00539	0.303	CrCbGaD
Agomelatine—Naproxen—UGT1A1—lung cancer	0.00221	0.124	CrCbGaD
Agomelatine—Indomethacin—ABCC3—lung cancer	0.00207	0.116	CrCbGaD
Agomelatine—Indomethacin—UGT1A1—lung cancer	0.00179	0.101	CrCbGaD
Agomelatine—Indomethacin—CXCL8—lung cancer	0.00169	0.0949	CrCbGaD
Agomelatine—Nabumetone—PTGS2—lung cancer	0.00132	0.0738	CrCbGaD
Agomelatine—Melatonin—CYP1A1—lung cancer	0.000838	0.047	CrCbGaD
Agomelatine—Weight increased—Docetaxel—lung cancer	0.000823	0.00196	CcSEcCtD
Agomelatine—Vertigo—Irinotecan—lung cancer	0.000819	0.00195	CcSEcCtD
Agomelatine—Weight decreased—Docetaxel—lung cancer	0.000818	0.00195	CcSEcCtD
Agomelatine—Eye disorder—Etoposide—lung cancer	0.000814	0.00194	CcSEcCtD
Agomelatine—Paraesthesia—Vinorelbine—lung cancer	0.00081	0.00193	CcSEcCtD
Agomelatine—Infestation NOS—Docetaxel—lung cancer	0.000806	0.00192	CcSEcCtD
Agomelatine—Infestation—Docetaxel—lung cancer	0.000806	0.00192	CcSEcCtD
Agomelatine—Eye disorder—Paclitaxel—lung cancer	0.000798	0.0019	CcSEcCtD
Agomelatine—Tinnitus—Paclitaxel—lung cancer	0.000796	0.0019	CcSEcCtD
Agomelatine—Jaundice—Docetaxel—lung cancer	0.000786	0.00187	CcSEcCtD
Agomelatine—Vision blurred—Cisplatin—lung cancer	0.00078	0.00186	CcSEcCtD
Agomelatine—Asthenia—Vinblastine—lung cancer	0.000778	0.00186	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000778	0.00186	CcSEcCtD
Agomelatine—Fatigue—Vinorelbine—lung cancer	0.000777	0.00185	CcSEcCtD
Agomelatine—Tremor—Cisplatin—lung cancer	0.000775	0.00185	CcSEcCtD
Agomelatine—Constipation—Vinorelbine—lung cancer	0.000771	0.00184	CcSEcCtD
Agomelatine—Hepatobiliary disease—Docetaxel—lung cancer	0.000762	0.00182	CcSEcCtD
Agomelatine—Asthenia—Topotecan—lung cancer	0.000756	0.0018	CcSEcCtD
Agomelatine—Blood alkaline phosphatase increased—Doxorubicin—lung cancer	0.00075	0.00179	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.00075	0.00179	CcSEcCtD
Agomelatine—Asthenia—Erlotinib—lung cancer	0.000748	0.00178	CcSEcCtD
Agomelatine—Mental disorder—Paclitaxel—lung cancer	0.000748	0.00178	CcSEcCtD
Agomelatine—Pruritus—Topotecan—lung cancer	0.000746	0.00178	CcSEcCtD
Agomelatine—Diarrhoea—Vinblastine—lung cancer	0.000742	0.00177	CcSEcCtD
Agomelatine—Infection—Irinotecan—lung cancer	0.000739	0.00176	CcSEcCtD
Agomelatine—Pruritus—Erlotinib—lung cancer	0.000738	0.00176	CcSEcCtD
Agomelatine—Gastrointestinal pain—Vinorelbine—lung cancer	0.000737	0.00176	CcSEcCtD
Agomelatine—Back pain—Etoposide—lung cancer	0.000733	0.00175	CcSEcCtD
Agomelatine—Nervous system disorder—Irinotecan—lung cancer	0.000729	0.00174	CcSEcCtD
Agomelatine—Eczema—Doxorubicin—lung cancer	0.000726	0.00173	CcSEcCtD
Agomelatine—Hepatic failure—Doxorubicin—lung cancer	0.000726	0.00173	CcSEcCtD
Agomelatine—Hepatitis—Docetaxel—lung cancer	0.000723	0.00172	CcSEcCtD
Agomelatine—Diarrhoea—Topotecan—lung cancer	0.000721	0.00172	CcSEcCtD
Agomelatine—Infection—Gemcitabine—lung cancer	0.00072	0.00172	CcSEcCtD
Agomelatine—Irritability—Methotrexate—lung cancer	0.000719	0.00172	CcSEcCtD
Agomelatine—Hyperhidrosis—Irinotecan—lung cancer	0.000719	0.00171	CcSEcCtD
Agomelatine—Back pain—Paclitaxel—lung cancer	0.000719	0.00171	CcSEcCtD
Agomelatine—Dizziness—Vinblastine—lung cancer	0.000717	0.00171	CcSEcCtD
Agomelatine—Urticaria—Vinorelbine—lung cancer	0.000716	0.00171	CcSEcCtD
Agomelatine—Diarrhoea—Erlotinib—lung cancer	0.000713	0.0017	CcSEcCtD
Agomelatine—Abdominal pain—Vinorelbine—lung cancer	0.000713	0.0017	CcSEcCtD
Agomelatine—Connective tissue disorder—Docetaxel—lung cancer	0.000711	0.0017	CcSEcCtD
Agomelatine—Nervous system disorder—Gemcitabine—lung cancer	0.00071	0.00169	CcSEcCtD
Agomelatine—Skin disorder—Gemcitabine—lung cancer	0.000704	0.00168	CcSEcCtD
Agomelatine—Anxiety—Cisplatin—lung cancer	0.000702	0.00167	CcSEcCtD
Agomelatine—Vision blurred—Paclitaxel—lung cancer	0.0007	0.00167	CcSEcCtD
Agomelatine—Hyperhidrosis—Gemcitabine—lung cancer	0.0007	0.00167	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000699	0.00167	CcSEcCtD
Agomelatine—Dizziness—Topotecan—lung cancer	0.000697	0.00166	CcSEcCtD
Agomelatine—Tremor—Paclitaxel—lung cancer	0.000696	0.00166	CcSEcCtD
Agomelatine—Vomiting—Vinblastine—lung cancer	0.00069	0.00164	CcSEcCtD
Agomelatine—Dizziness—Erlotinib—lung cancer	0.00069	0.00164	CcSEcCtD
Agomelatine—Agitation—Paclitaxel—lung cancer	0.000683	0.00163	CcSEcCtD
Agomelatine—Vertigo—Etoposide—lung cancer	0.000681	0.00162	CcSEcCtD
Agomelatine—Headache—Vinblastine—lung cancer	0.00068	0.00162	CcSEcCtD
Agomelatine—Angioedema—Paclitaxel—lung cancer	0.000679	0.00162	CcSEcCtD
Agomelatine—Eye disorder—Docetaxel—lung cancer	0.000676	0.00161	CcSEcCtD
Agomelatine—Insomnia—Irinotecan—lung cancer	0.000673	0.0016	CcSEcCtD
Agomelatine—Infection—Cisplatin—lung cancer	0.000671	0.0016	CcSEcCtD
Agomelatine—Vomiting—Topotecan—lung cancer	0.00067	0.0016	CcSEcCtD
Agomelatine—Paraesthesia—Irinotecan—lung cancer	0.000668	0.00159	CcSEcCtD
Agomelatine—Vertigo—Paclitaxel—lung cancer	0.000668	0.00159	CcSEcCtD
Agomelatine—Vomiting—Erlotinib—lung cancer	0.000663	0.00158	CcSEcCtD
Agomelatine—Nervous system disorder—Cisplatin—lung cancer	0.000662	0.00158	CcSEcCtD
Agomelatine—Somnolence—Irinotecan—lung cancer	0.000661	0.00158	CcSEcCtD
Agomelatine—Headache—Topotecan—lung cancer	0.00066	0.00157	CcSEcCtD
Agomelatine—Skin disorder—Cisplatin—lung cancer	0.000656	0.00156	CcSEcCtD
Agomelatine—Insomnia—Gemcitabine—lung cancer	0.000655	0.00156	CcSEcCtD
Agomelatine—Dyspepsia—Irinotecan—lung cancer	0.000655	0.00156	CcSEcCtD
Agomelatine—Headache—Erlotinib—lung cancer	0.000653	0.00156	CcSEcCtD
Agomelatine—Hyperhidrosis—Cisplatin—lung cancer	0.000653	0.00156	CcSEcCtD
Agomelatine—Paraesthesia—Gemcitabine—lung cancer	0.00065	0.00155	CcSEcCtD
Agomelatine—Asthenia—Vinorelbine—lung cancer	0.000647	0.00154	CcSEcCtD
Agomelatine—Nausea—Vinblastine—lung cancer	0.000644	0.00154	CcSEcCtD
Agomelatine—Somnolence—Gemcitabine—lung cancer	0.000644	0.00154	CcSEcCtD
Agomelatine—Migraine—Doxorubicin—lung cancer	0.000642	0.00153	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Irinotecan—lung cancer	0.000642	0.00153	CcSEcCtD
Agomelatine—Fatigue—Irinotecan—lung cancer	0.000641	0.00153	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000641	0.00153	CcSEcCtD
Agomelatine—Pruritus—Vinorelbine—lung cancer	0.000638	0.00152	CcSEcCtD
Agomelatine—Constipation—Irinotecan—lung cancer	0.000636	0.00152	CcSEcCtD
Agomelatine—Mental disorder—Docetaxel—lung cancer	0.000634	0.00151	CcSEcCtD
Agomelatine—Anxiety—Paclitaxel—lung cancer	0.00063	0.0015	CcSEcCtD
Agomelatine—Face oedema—Doxorubicin—lung cancer	0.00063	0.0015	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000628	0.0015	CcSEcCtD
Agomelatine—Nausea—Topotecan—lung cancer	0.000626	0.00149	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000625	0.00149	CcSEcCtD
Agomelatine—Fatigue—Gemcitabine—lung cancer	0.000624	0.00149	CcSEcCtD
Agomelatine—Constipation—Gemcitabine—lung cancer	0.000619	0.00148	CcSEcCtD
Agomelatine—Nausea—Erlotinib—lung cancer	0.000619	0.00148	CcSEcCtD
Agomelatine—Dry mouth—Paclitaxel—lung cancer	0.000619	0.00148	CcSEcCtD
Agomelatine—Diarrhoea—Vinorelbine—lung cancer	0.000617	0.00147	CcSEcCtD
Agomelatine—Infection—Etoposide—lung cancer	0.000614	0.00147	CcSEcCtD
Agomelatine—Back pain—Docetaxel—lung cancer	0.000609	0.00145	CcSEcCtD
Agomelatine—Naproxen—PTGS2—lung cancer	0.000609	0.0342	CrCbGaD
Agomelatine—Gastrointestinal pain—Irinotecan—lung cancer	0.000608	0.00145	CcSEcCtD
Agomelatine—Paraesthesia—Cisplatin—lung cancer	0.000606	0.00145	CcSEcCtD
Agomelatine—Infection—Paclitaxel—lung cancer	0.000602	0.00144	CcSEcCtD
Agomelatine—Skin disorder—Etoposide—lung cancer	0.000601	0.00143	CcSEcCtD
Agomelatine—Hyperhidrosis—Etoposide—lung cancer	0.000598	0.00143	CcSEcCtD
Agomelatine—Dizziness—Vinorelbine—lung cancer	0.000596	0.00142	CcSEcCtD
Agomelatine—Nervous system disorder—Paclitaxel—lung cancer	0.000595	0.00142	CcSEcCtD
Agomelatine—Skin disorder—Paclitaxel—lung cancer	0.000589	0.0014	CcSEcCtD
Agomelatine—Abdominal pain—Irinotecan—lung cancer	0.000588	0.0014	CcSEcCtD
Agomelatine—Hyperhidrosis—Paclitaxel—lung cancer	0.000586	0.0014	CcSEcCtD
Agomelatine—Nasopharyngitis—Doxorubicin—lung cancer	0.000584	0.00139	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Cisplatin—lung cancer	0.000583	0.00139	CcSEcCtD
Agomelatine—Infestation NOS—Methotrexate—lung cancer	0.000581	0.00138	CcSEcCtD
Agomelatine—Infestation—Methotrexate—lung cancer	0.000581	0.00138	CcSEcCtD
Agomelatine—Depression—Methotrexate—lung cancer	0.000579	0.00138	CcSEcCtD
Agomelatine—Vomiting—Vinorelbine—lung cancer	0.000573	0.00137	CcSEcCtD
Agomelatine—Headache—Vinorelbine—lung cancer	0.000565	0.00135	CcSEcCtD
Agomelatine—Influenza—Doxorubicin—lung cancer	0.000564	0.00134	CcSEcCtD
Agomelatine—Paraesthesia—Etoposide—lung cancer	0.000555	0.00132	CcSEcCtD
Agomelatine—Somnolence—Etoposide—lung cancer	0.00055	0.00131	CcSEcCtD
Agomelatine—Hepatobiliary disease—Methotrexate—lung cancer	0.000549	0.00131	CcSEcCtD
Agomelatine—Insomnia—Paclitaxel—lung cancer	0.000548	0.00131	CcSEcCtD
Agomelatine—Paraesthesia—Paclitaxel—lung cancer	0.000545	0.0013	CcSEcCtD
Agomelatine—Naproxen—ALB—lung cancer	0.000542	0.0304	CrCbGaD
Agomelatine—Somnolence—Paclitaxel—lung cancer	0.000539	0.00129	CcSEcCtD
Agomelatine—Nausea—Vinorelbine—lung cancer	0.000536	0.00128	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Etoposide—lung cancer	0.000534	0.00127	CcSEcCtD
Agomelatine—Dyspepsia—Paclitaxel—lung cancer	0.000534	0.00127	CcSEcCtD
Agomelatine—Asthenia—Irinotecan—lung cancer	0.000533	0.00127	CcSEcCtD
Agomelatine—Fatigue—Etoposide—lung cancer	0.000533	0.00127	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000532	0.00127	CcSEcCtD
Agomelatine—Constipation—Etoposide—lung cancer	0.000529	0.00126	CcSEcCtD
Agomelatine—Dry mouth—Docetaxel—lung cancer	0.000524	0.00125	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000524	0.00125	CcSEcCtD
Agomelatine—Fatigue—Paclitaxel—lung cancer	0.000523	0.00125	CcSEcCtD
Agomelatine—Hepatitis—Methotrexate—lung cancer	0.000521	0.00124	CcSEcCtD
Agomelatine—Asthenia—Gemcitabine—lung cancer	0.00052	0.00124	CcSEcCtD
Agomelatine—Constipation—Paclitaxel—lung cancer	0.000519	0.00124	CcSEcCtD
Agomelatine—Weight increased—Doxorubicin—lung cancer	0.000513	0.00122	CcSEcCtD
Agomelatine—Pruritus—Gemcitabine—lung cancer	0.000512	0.00122	CcSEcCtD
Agomelatine—Infection—Docetaxel—lung cancer	0.000511	0.00122	CcSEcCtD
Agomelatine—Weight decreased—Doxorubicin—lung cancer	0.00051	0.00122	CcSEcCtD
Agomelatine—Diarrhoea—Irinotecan—lung cancer	0.000509	0.00121	CcSEcCtD
Agomelatine—Gastrointestinal pain—Etoposide—lung cancer	0.000506	0.00121	CcSEcCtD
Agomelatine—Nervous system disorder—Docetaxel—lung cancer	0.000504	0.0012	CcSEcCtD
Agomelatine—Infestation NOS—Doxorubicin—lung cancer	0.000503	0.0012	CcSEcCtD
Agomelatine—Infestation—Doxorubicin—lung cancer	0.000503	0.0012	CcSEcCtD
Agomelatine—Skin disorder—Docetaxel—lung cancer	0.000499	0.00119	CcSEcCtD
Agomelatine—Gastrointestinal pain—Paclitaxel—lung cancer	0.000496	0.00118	CcSEcCtD
Agomelatine—Diarrhoea—Gemcitabine—lung cancer	0.000496	0.00118	CcSEcCtD
Agomelatine—Indomethacin—PTGS2—lung cancer	0.000493	0.0277	CrCbGaD
Agomelatine—Dizziness—Irinotecan—lung cancer	0.000492	0.00117	CcSEcCtD
Agomelatine—Urticaria—Etoposide—lung cancer	0.000491	0.00117	CcSEcCtD
Agomelatine—Jaundice—Doxorubicin—lung cancer	0.00049	0.00117	CcSEcCtD
Agomelatine—Abdominal pain—Etoposide—lung cancer	0.000489	0.00117	CcSEcCtD
Agomelatine—Eye disorder—Methotrexate—lung cancer	0.000487	0.00116	CcSEcCtD
Agomelatine—Tinnitus—Methotrexate—lung cancer	0.000486	0.00116	CcSEcCtD
Agomelatine—Asthenia—Cisplatin—lung cancer	0.000484	0.00115	CcSEcCtD
Agomelatine—Urticaria—Paclitaxel—lung cancer	0.000482	0.00115	CcSEcCtD
Agomelatine—Abdominal pain—Paclitaxel—lung cancer	0.000479	0.00114	CcSEcCtD
Agomelatine—Hepatobiliary disease—Doxorubicin—lung cancer	0.000476	0.00113	CcSEcCtD
Agomelatine—Vomiting—Irinotecan—lung cancer	0.000473	0.00113	CcSEcCtD
Agomelatine—Headache—Irinotecan—lung cancer	0.000466	0.00111	CcSEcCtD
Agomelatine—Insomnia—Docetaxel—lung cancer	0.000465	0.00111	CcSEcCtD
Agomelatine—Diarrhoea—Cisplatin—lung cancer	0.000462	0.0011	CcSEcCtD
Agomelatine—Paraesthesia—Docetaxel—lung cancer	0.000462	0.0011	CcSEcCtD
Agomelatine—Vomiting—Gemcitabine—lung cancer	0.000461	0.0011	CcSEcCtD
Agomelatine—Somnolence—Docetaxel—lung cancer	0.000457	0.00109	CcSEcCtD
Agomelatine—Mental disorder—Methotrexate—lung cancer	0.000457	0.00109	CcSEcCtD
Agomelatine—Headache—Gemcitabine—lung cancer	0.000454	0.00108	CcSEcCtD
Agomelatine—Dyspepsia—Docetaxel—lung cancer	0.000452	0.00108	CcSEcCtD
Agomelatine—Hepatitis—Doxorubicin—lung cancer	0.000452	0.00108	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Docetaxel—lung cancer	0.000444	0.00106	CcSEcCtD
Agomelatine—Asthenia—Etoposide—lung cancer	0.000444	0.00106	CcSEcCtD
Agomelatine—Connective tissue disorder—Doxorubicin—lung cancer	0.000444	0.00106	CcSEcCtD
Agomelatine—Fatigue—Docetaxel—lung cancer	0.000443	0.00106	CcSEcCtD
Agomelatine—Nausea—Irinotecan—lung cancer	0.000442	0.00105	CcSEcCtD
Agomelatine—Constipation—Docetaxel—lung cancer	0.00044	0.00105	CcSEcCtD
Agomelatine—Indomethacin—ALB—lung cancer	0.000439	0.0247	CrCbGaD
Agomelatine—Back pain—Methotrexate—lung cancer	0.000439	0.00105	CcSEcCtD
Agomelatine—Pruritus—Etoposide—lung cancer	0.000438	0.00104	CcSEcCtD
Agomelatine—Asthenia—Paclitaxel—lung cancer	0.000435	0.00104	CcSEcCtD
Agomelatine—Nausea—Gemcitabine—lung cancer	0.00043	0.00103	CcSEcCtD
Agomelatine—Vomiting—Cisplatin—lung cancer	0.000429	0.00102	CcSEcCtD
Agomelatine—Pruritus—Paclitaxel—lung cancer	0.000429	0.00102	CcSEcCtD
Agomelatine—Vision blurred—Methotrexate—lung cancer	0.000428	0.00102	CcSEcCtD
Agomelatine—Diarrhoea—Etoposide—lung cancer	0.000423	0.00101	CcSEcCtD
Agomelatine—Eye disorder—Doxorubicin—lung cancer	0.000422	0.00101	CcSEcCtD
Agomelatine—Tinnitus—Doxorubicin—lung cancer	0.000421	0.001	CcSEcCtD
Agomelatine—Gastrointestinal pain—Docetaxel—lung cancer	0.00042	0.001	CcSEcCtD
Agomelatine—Indomethacin—ABCB1—lung cancer	0.000419	0.0235	CrCbGaD
Agomelatine—Diarrhoea—Paclitaxel—lung cancer	0.000415	0.000989	CcSEcCtD
Agomelatine—Dizziness—Etoposide—lung cancer	0.000409	0.000975	CcSEcCtD
Agomelatine—Vertigo—Methotrexate—lung cancer	0.000408	0.000972	CcSEcCtD
Agomelatine—Abdominal pain—Docetaxel—lung cancer	0.000406	0.000969	CcSEcCtD
Agomelatine—Dizziness—Paclitaxel—lung cancer	0.000401	0.000956	CcSEcCtD
Agomelatine—Nausea—Cisplatin—lung cancer	0.000401	0.000956	CcSEcCtD
Agomelatine—Mental disorder—Doxorubicin—lung cancer	0.000396	0.000943	CcSEcCtD
Agomelatine—Vomiting—Etoposide—lung cancer	0.000393	0.000938	CcSEcCtD
Agomelatine—Headache—Etoposide—lung cancer	0.000387	0.000924	CcSEcCtD
Agomelatine—Vomiting—Paclitaxel—lung cancer	0.000386	0.000919	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000384	0.000915	CcSEcCtD
Agomelatine—Back pain—Doxorubicin—lung cancer	0.00038	0.000907	CcSEcCtD
Agomelatine—Headache—Paclitaxel—lung cancer	0.00038	0.000906	CcSEcCtD
Agomelatine—Vision blurred—Doxorubicin—lung cancer	0.00037	0.000883	CcSEcCtD
Agomelatine—Asthenia—Docetaxel—lung cancer	0.000369	0.000879	CcSEcCtD
Agomelatine—Infection—Methotrexate—lung cancer	0.000368	0.000878	CcSEcCtD
Agomelatine—Nausea—Etoposide—lung cancer	0.000367	0.000876	CcSEcCtD
Agomelatine—Pruritus—Docetaxel—lung cancer	0.000364	0.000867	CcSEcCtD
Agomelatine—Nervous system disorder—Methotrexate—lung cancer	0.000363	0.000866	CcSEcCtD
Agomelatine—Agitation—Doxorubicin—lung cancer	0.000361	0.000861	CcSEcCtD
Agomelatine—Nausea—Paclitaxel—lung cancer	0.00036	0.000859	CcSEcCtD
Agomelatine—Skin disorder—Methotrexate—lung cancer	0.00036	0.000858	CcSEcCtD
Agomelatine—Hyperhidrosis—Methotrexate—lung cancer	0.000358	0.000854	CcSEcCtD
Agomelatine—Vertigo—Doxorubicin—lung cancer	0.000353	0.000842	CcSEcCtD
Agomelatine—Diarrhoea—Docetaxel—lung cancer	0.000352	0.000839	CcSEcCtD
Agomelatine—Dizziness—Docetaxel—lung cancer	0.00034	0.00081	CcSEcCtD
Agomelatine—Insomnia—Methotrexate—lung cancer	0.000335	0.000799	CcSEcCtD
Agomelatine—Anxiety—Doxorubicin—lung cancer	0.000333	0.000795	CcSEcCtD
Agomelatine—Paraesthesia—Methotrexate—lung cancer	0.000333	0.000793	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000332	0.000792	CcSEcCtD
Agomelatine—Somnolence—Methotrexate—lung cancer	0.000329	0.000785	CcSEcCtD
Agomelatine—Dry mouth—Doxorubicin—lung cancer	0.000327	0.00078	CcSEcCtD
Agomelatine—Vomiting—Docetaxel—lung cancer	0.000327	0.000779	CcSEcCtD
Agomelatine—Dyspepsia—Methotrexate—lung cancer	0.000326	0.000778	CcSEcCtD
Agomelatine—Headache—Docetaxel—lung cancer	0.000322	0.000768	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Methotrexate—lung cancer	0.00032	0.000763	CcSEcCtD
Agomelatine—Fatigue—Methotrexate—lung cancer	0.000319	0.000762	CcSEcCtD
Agomelatine—Infection—Doxorubicin—lung cancer	0.000319	0.00076	CcSEcCtD
Agomelatine—Nervous system disorder—Doxorubicin—lung cancer	0.000315	0.00075	CcSEcCtD
Agomelatine—Skin disorder—Doxorubicin—lung cancer	0.000312	0.000743	CcSEcCtD
Agomelatine—Hyperhidrosis—Doxorubicin—lung cancer	0.00031	0.000739	CcSEcCtD
Agomelatine—Nausea—Docetaxel—lung cancer	0.000305	0.000728	CcSEcCtD
Agomelatine—Gastrointestinal pain—Methotrexate—lung cancer	0.000303	0.000722	CcSEcCtD
Agomelatine—Urticaria—Methotrexate—lung cancer	0.000294	0.000702	CcSEcCtD
Agomelatine—Abdominal pain—Methotrexate—lung cancer	0.000293	0.000698	CcSEcCtD
Agomelatine—Insomnia—Doxorubicin—lung cancer	0.00029	0.000692	CcSEcCtD
Agomelatine—Paraesthesia—Doxorubicin—lung cancer	0.000288	0.000687	CcSEcCtD
Agomelatine—Somnolence—Doxorubicin—lung cancer	0.000285	0.00068	CcSEcCtD
Agomelatine—Dyspepsia—Doxorubicin—lung cancer	0.000282	0.000673	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000277	0.00066	CcSEcCtD
Agomelatine—Fatigue—Doxorubicin—lung cancer	0.000277	0.000659	CcSEcCtD
Agomelatine—Constipation—Doxorubicin—lung cancer	0.000274	0.000654	CcSEcCtD
Agomelatine—Asthenia—Methotrexate—lung cancer	0.000266	0.000634	CcSEcCtD
Agomelatine—Gastrointestinal pain—Doxorubicin—lung cancer	0.000262	0.000625	CcSEcCtD
Agomelatine—Pruritus—Methotrexate—lung cancer	0.000262	0.000625	CcSEcCtD
Agomelatine—Urticaria—Doxorubicin—lung cancer	0.000255	0.000608	CcSEcCtD
Agomelatine—Abdominal pain—Doxorubicin—lung cancer	0.000254	0.000605	CcSEcCtD
Agomelatine—Diarrhoea—Methotrexate—lung cancer	0.000253	0.000604	CcSEcCtD
Agomelatine—Dizziness—Methotrexate—lung cancer	0.000245	0.000584	CcSEcCtD
Agomelatine—Vomiting—Methotrexate—lung cancer	0.000236	0.000562	CcSEcCtD
Agomelatine—Headache—Methotrexate—lung cancer	0.000232	0.000553	CcSEcCtD
Agomelatine—Asthenia—Doxorubicin—lung cancer	0.00023	0.000549	CcSEcCtD
Agomelatine—Pruritus—Doxorubicin—lung cancer	0.000227	0.000541	CcSEcCtD
Agomelatine—Nausea—Methotrexate—lung cancer	0.00022	0.000525	CcSEcCtD
Agomelatine—Diarrhoea—Doxorubicin—lung cancer	0.000219	0.000523	CcSEcCtD
Agomelatine—Dizziness—Doxorubicin—lung cancer	0.000212	0.000506	CcSEcCtD
Agomelatine—Vomiting—Doxorubicin—lung cancer	0.000204	0.000486	CcSEcCtD
Agomelatine—Headache—Doxorubicin—lung cancer	0.000201	0.000479	CcSEcCtD
Agomelatine—Nausea—Doxorubicin—lung cancer	0.000191	0.000454	CcSEcCtD
Agomelatine—HTR2B—Signaling Pathways—AVP—lung cancer	4.56e-05	0.000185	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—POMC—lung cancer	4.56e-05	0.000185	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—PIK3CB—lung cancer	4.55e-05	0.000184	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	4.5e-05	0.000182	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GSTA2—lung cancer	4.49e-05	0.000182	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—JUNB—lung cancer	4.48e-05	0.000181	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TP53—lung cancer	4.46e-05	0.000181	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TP53—lung cancer	4.46e-05	0.000181	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IGF1R—lung cancer	4.39e-05	0.000178	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CXCL8—lung cancer	4.37e-05	0.000177	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PIK3CG—lung cancer	4.35e-05	0.000176	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GSTA1—lung cancer	4.33e-05	0.000175	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HES1—lung cancer	4.32e-05	0.000175	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—RRM1—lung cancer	4.3e-05	0.000174	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GSTA3—lung cancer	4.3e-05	0.000174	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ABCC3—lung cancer	4.28e-05	0.000173	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—HRAS—lung cancer	4.27e-05	0.000173	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—HRAS—lung cancer	4.27e-05	0.000173	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—RAF1—lung cancer	4.23e-05	0.000171	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PIK3CD—lung cancer	4.21e-05	0.000171	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—IL2—lung cancer	4.18e-05	0.000169	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—AKR1C1—lung cancer	4.14e-05	0.000168	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—POMC—lung cancer	4.14e-05	0.000168	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—PIK3CB—lung cancer	4.13e-05	0.000167	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IL6—lung cancer	4.08e-05	0.000165	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IL6—lung cancer	4.08e-05	0.000165	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—STK11—lung cancer	4.07e-05	0.000165	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—B4GALT5—lung cancer	4.04e-05	0.000164	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—IL6R—lung cancer	4.04e-05	0.000164	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—UGT1A1—lung cancer	4.02e-05	0.000163	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CXCL8—lung cancer	3.97e-05	0.000161	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ERBB3—lung cancer	3.95e-05	0.00016	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GSTA4—lung cancer	3.93e-05	0.000159	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—FOXO3—lung cancer	3.93e-05	0.000159	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GNG11—lung cancer	3.88e-05	0.000157	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	3.86e-05	0.000156	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—MAP2K1—lung cancer	3.85e-05	0.000156	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	3.84e-05	0.000156	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GSTA2—lung cancer	3.83e-05	0.000155	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PIK3CD—lung cancer	3.83e-05	0.000155	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—IL2—lung cancer	3.8e-05	0.000154	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TERT—lung cancer	3.78e-05	0.000153	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—AKT1—lung cancer	3.77e-05	0.000152	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—AKT1—lung cancer	3.77e-05	0.000152	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GSTA1—lung cancer	3.7e-05	0.00015	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ALDOA—lung cancer	3.69e-05	0.000149	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AVP—lung cancer	3.68e-05	0.000149	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—FGFR1—lung cancer	3.67e-05	0.000149	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PIK3CB—lung cancer	3.67e-05	0.000149	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ABCC3—lung cancer	3.66e-05	0.000148	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HIF1A—lung cancer	3.62e-05	0.000146	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—NCOA3—lung cancer	3.59e-05	0.000145	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IGF1R—lung cancer	3.54e-05	0.000143	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—AKR1C1—lung cancer	3.54e-05	0.000143	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CXCL8—lung cancer	3.53e-05	0.000143	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.52e-05	0.000143	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—APOA1—lung cancer	3.49e-05	0.000141	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ABCG2—lung cancer	3.49e-05	0.000141	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ADCY1—lung cancer	3.49e-05	0.000141	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HES1—lung cancer	3.48e-05	0.000141	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—KDR—lung cancer	3.46e-05	0.00014	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—UGT1A1—lung cancer	3.44e-05	0.000139	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—HPGDS—lung cancer	3.42e-05	0.000138	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ENO2—lung cancer	3.42e-05	0.000138	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—RAF1—lung cancer	3.42e-05	0.000138	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PPP2R1B—lung cancer	3.4e-05	0.000138	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—IL2—lung cancer	3.37e-05	0.000136	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	3.35e-05	0.000136	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PIK3CB—lung cancer	3.33e-05	0.000135	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GSTT1—lung cancer	3.32e-05	0.000134	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GNG11—lung cancer	3.31e-05	0.000134	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	3.3e-05	0.000133	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GCLC—lung cancer	3.28e-05	0.000133	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP2A6—lung cancer	3.28e-05	0.000133	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	3.27e-05	0.000132	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CXCL8—lung cancer	3.2e-05	0.00013	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—APC—lung cancer	3.19e-05	0.000129	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PIK3CG—lung cancer	3.19e-05	0.000129	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—KIT—lung cancer	3.19e-05	0.000129	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—NRAS—lung cancer	3.19e-05	0.000129	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ERBB3—lung cancer	3.18e-05	0.000129	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ALDOA—lung cancer	3.16e-05	0.000128	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—EGF—lung cancer	3.15e-05	0.000127	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ENO1—lung cancer	3.11e-05	0.000126	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.1e-05	0.000125	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NCOA3—lung cancer	3.06e-05	0.000124	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—IL2—lung cancer	3.06e-05	0.000124	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.06e-05	0.000124	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—MAPK3—lung cancer	3.05e-05	0.000124	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TERT—lung cancer	3.05e-05	0.000123	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—POMC—lung cancer	3.03e-05	0.000123	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.01e-05	0.000122	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—BRAF—lung cancer	3e-05	0.000121	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ABCG2—lung cancer	2.98e-05	0.000121	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ADCY1—lung cancer	2.98e-05	0.000121	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—FGFR1—lung cancer	2.96e-05	0.00012	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IL6R—lung cancer	2.96e-05	0.00012	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CREBBP—lung cancer	2.95e-05	0.00012	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—HPGDS—lung cancer	2.92e-05	0.000118	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ENO2—lung cancer	2.92e-05	0.000118	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HIF1A—lung cancer	2.92e-05	0.000118	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PPP2R1B—lung cancer	2.9e-05	0.000118	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—EGFR—lung cancer	2.9e-05	0.000117	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.87e-05	0.000116	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GSTT1—lung cancer	2.84e-05	0.000115	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MAP2K1—lung cancer	2.82e-05	0.000114	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—APOA1—lung cancer	2.82e-05	0.000114	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP2A6—lung cancer	2.8e-05	0.000113	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GCLC—lung cancer	2.8e-05	0.000113	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PIK3CD—lung cancer	2.8e-05	0.000113	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.79e-05	0.000113	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—KDR—lung cancer	2.79e-05	0.000113	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP2E1—lung cancer	2.79e-05	0.000113	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—PIK3CA—lung cancer	2.77e-05	0.000112	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—NQO1—lung cancer	2.76e-05	0.000112	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—KRAS—lung cancer	2.74e-05	0.000111	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.7e-05	0.000109	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.68e-05	0.000108	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ENO1—lung cancer	2.66e-05	0.000108	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.65e-05	0.000107	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.61e-05	0.000106	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—APC—lung cancer	2.57e-05	0.000104	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PIK3CG—lung cancer	2.57e-05	0.000104	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—KIT—lung cancer	2.57e-05	0.000104	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—NRAS—lung cancer	2.57e-05	0.000104	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—EGF—lung cancer	2.54e-05	0.000103	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—PIK3CA—lung cancer	2.52e-05	0.000102	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MDM2—lung cancer	2.51e-05	0.000102	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—RAF1—lung cancer	2.5e-05	0.000101	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—STK11—lung cancer	2.49e-05	0.000101	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ERBB2—lung cancer	2.47e-05	0.0001	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—MAPK3—lung cancer	2.46e-05	9.96e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—POMC—lung cancer	2.45e-05	9.9e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PIK3CB—lung cancer	2.44e-05	9.88e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MTOR—lung cancer	2.44e-05	9.88e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—BRAF—lung cancer	2.42e-05	9.78e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IL6R—lung cancer	2.39e-05	9.66e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CREBBP—lung cancer	2.38e-05	9.65e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP2E1—lung cancer	2.38e-05	9.64e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NQO1—lung cancer	2.36e-05	9.54e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CXCL8—lung cancer	2.35e-05	9.5e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—EGFR—lung cancer	2.34e-05	9.48e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.33e-05	9.44e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—HRAS—lung cancer	2.33e-05	9.43e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.31e-05	9.34e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GSTP1—lung cancer	2.3e-05	9.31e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.29e-05	9.25e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MAP2K1—lung cancer	2.28e-05	9.21e-05	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—AKT1—lung cancer	2.27e-05	9.17e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PIK3CD—lung cancer	2.26e-05	9.15e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CASP3—lung cancer	2.25e-05	9.09e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IL2—lung cancer	2.24e-05	9.08e-05	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PIK3CA—lung cancer	2.24e-05	9.06e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CAT—lung cancer	2.24e-05	9.06e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—IL6—lung cancer	2.23e-05	9.03e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.22e-05	9e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—KRAS—lung cancer	2.21e-05	8.96e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCND1—lung cancer	2.19e-05	8.85e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—JUN—lung cancer	2.18e-05	8.83e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ABCB1—lung cancer	2.18e-05	8.81e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—TYMS—lung cancer	2.14e-05	8.65e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—STK11—lung cancer	2.12e-05	8.6e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MMP9—lung cancer	2.12e-05	8.59e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CDKN1A—lung cancer	2.11e-05	8.56e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GSTM1—lung cancer	2.11e-05	8.55e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PTEN—lung cancer	2.11e-05	8.54e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—AKT1—lung cancer	2.06e-05	8.33e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PIK3CA—lung cancer	2.03e-05	8.23e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MDM2—lung cancer	2.02e-05	8.19e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—RAF1—lung cancer	2.02e-05	8.17e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—EP300—lung cancer	2.01e-05	8.14e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP1A1—lung cancer	2e-05	8.11e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ERBB2—lung cancer	2e-05	8.08e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.99e-05	8.07e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ERCC2—lung cancer	1.99e-05	8.04e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PIK3CB—lung cancer	1.97e-05	7.97e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MTOR—lung cancer	1.97e-05	7.97e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GSTP1—lung cancer	1.97e-05	7.95e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SRC—lung cancer	1.96e-05	7.92e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CAT—lung cancer	1.91e-05	7.74e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—VEGFA—lung cancer	1.91e-05	7.71e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.9e-05	7.69e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CXCL8—lung cancer	1.89e-05	7.66e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—STAT3—lung cancer	1.89e-05	7.64e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NRAS—lung cancer	1.88e-05	7.62e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—HRAS—lung cancer	1.88e-05	7.61e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ABCB1—lung cancer	1.86e-05	7.53e-05	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—AKT1—lung cancer	1.83e-05	7.4e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—TYMS—lung cancer	1.83e-05	7.39e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CASP3—lung cancer	1.81e-05	7.33e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IL2—lung cancer	1.81e-05	7.32e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GSTM1—lung cancer	1.81e-05	7.31e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MAPK3—lung cancer	1.8e-05	7.3e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—IL6—lung cancer	1.8e-05	7.29e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCND1—lung cancer	1.76e-05	7.14e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—JUN—lung cancer	1.76e-05	7.12e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MYC—lung cancer	1.75e-05	7.1e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APOA1—lung cancer	1.72e-05	6.96e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—EGFR—lung cancer	1.72e-05	6.94e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MMP9—lung cancer	1.71e-05	6.93e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP1A1—lung cancer	1.71e-05	6.93e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CDKN1A—lung cancer	1.71e-05	6.9e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PTEN—lung cancer	1.7e-05	6.89e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ERCC2—lung cancer	1.7e-05	6.87e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—AKT1—lung cancer	1.66e-05	6.72e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.65e-05	6.66e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—EP300—lung cancer	1.62e-05	6.57e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—KRAS—lung cancer	1.62e-05	6.56e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SRC—lung cancer	1.58e-05	6.39e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PIK3CG—lung cancer	1.57e-05	6.35e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—VEGFA—lung cancer	1.54e-05	6.22e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—STAT3—lung cancer	1.52e-05	6.16e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NRAS—lung cancer	1.52e-05	6.15e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—POMC—lung cancer	1.49e-05	6.04e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PIK3CA—lung cancer	1.49e-05	6.02e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APOA1—lung cancer	1.47e-05	5.94e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CREBBP—lung cancer	1.45e-05	5.89e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MAPK3—lung cancer	1.45e-05	5.89e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TP53—lung cancer	1.44e-05	5.83e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MYC—lung cancer	1.41e-05	5.73e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.41e-05	5.69e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—EGFR—lung cancer	1.38e-05	5.6e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PIK3CD—lung cancer	1.38e-05	5.58e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HRAS—lung cancer	1.38e-05	5.57e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ALB—lung cancer	1.36e-05	5.51e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PIK3CG—lung cancer	1.34e-05	5.43e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IL6—lung cancer	1.32e-05	5.33e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—KRAS—lung cancer	1.31e-05	5.29e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—POMC—lung cancer	1.28e-05	5.17e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CREBBP—lung cancer	1.24e-05	5.03e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AKT1—lung cancer	1.22e-05	4.92e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PIK3CB—lung cancer	1.2e-05	4.87e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PIK3CA—lung cancer	1.2e-05	4.86e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PTGS2—lung cancer	1.19e-05	4.82e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PIK3CD—lung cancer	1.18e-05	4.77e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ALB—lung cancer	1.16e-05	4.71e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TP53—lung cancer	1.16e-05	4.7e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HRAS—lung cancer	1.11e-05	4.5e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IL6—lung cancer	1.06e-05	4.3e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PTEN—lung cancer	1.04e-05	4.2e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PIK3CB—lung cancer	1.03e-05	4.16e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PTGS2—lung cancer	1.02e-05	4.12e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—EP300—lung cancer	9.91e-06	4.01e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AKT1—lung cancer	9.81e-06	3.97e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PTEN—lung cancer	8.88e-06	3.59e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—EP300—lung cancer	8.47e-06	3.43e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PIK3CA—lung cancer	7.33e-06	2.97e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PIK3CA—lung cancer	6.26e-06	2.53e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—AKT1—lung cancer	5.99e-06	2.42e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—AKT1—lung cancer	5.12e-06	2.07e-05	CbGpPWpGaD
